PLXGX
Price
$20.41
Change
+$0.20 (+0.99%)
Updated
Apr 2 closing price
Net Assets
594.08M
RGABX
Price
$63.09
Change
+$0.64 (+1.02%)
Updated
Apr 2 closing price
Net Assets
275.25B
Ad is loading...

PLXGX vs RGABX

Header iconPLXGX vs RGABX Comparison
Open Charts PLXGX vs RGABXBanner chart's image
Virtus KAR Capital Growth I
Price$20.41
Change+$0.20 (+0.99%)
VolumeN/A
Net Assets594.08M
American Funds Growth Fund of Amer R2
Price$63.09
Change+$0.64 (+1.02%)
VolumeN/A
Net Assets275.25B
PLXGX vs RGABX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PLXGX vs. RGABX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLXGX is a Buy and RGABX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 275B vs. PLXGX (594M). PLXGX (0.00) and RGABX (0.00) have matching dividends . PLXGX was incepted earlier than RGABX: PLXGX (19 years) vs RGABX (23 years). RGABX (1.39) is less costly to investors than PLXGX (0.99). RGABX is a more actively managed with annual turnover of: 25.00 vs. PLXGX (14.00). RGABX has a lower initial minimum investment than PLXGX: RGABX (250) vs PLXGX (100000). RGABX annual gain was more profitable for investors over the last year : -0.79 vs. PLXGX (-7.25). RGABX return over 5 years is better than : 61.44 vs. PLXGX (30.30).
PLXGXRGABXPLXGX / RGABX
Total Expense Ratio0.991.3971%
Annual Report Gross Expense Ratio0.991.3971%
Fund Existence19 years23 years-
Gain YTD-5.912-5.014118%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets594M275B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-7.25-0.79922%
Returns for 3 years-18.933.04-623%
Returns for 5 years30.3061.4449%
Returns for 10 years39.4848.4182%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMO0.650.08
+14.58%
Sangamo Therapeutics
NTLA7.300.65
+9.69%
Intellia Therapeutics
FNF66.590.67
+1.02%
Fidelity National Financial
MCY56.370.22
+0.39%
Mercury General Corp
SCKT1.11N/A
N/A
Socket Mobile